171 related articles for article (PubMed ID: 35340062)
1. Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment.
Geusens P; Bevers MS; van Rietbergen B; Messina OD; Lespessailles E; Oliveri B; Chapurlat R; Engelke K; Chines A; Huang S; Saag KG; van den Bergh JP
J Bone Miner Res; 2022 Jun; 37(6):1136-1146. PubMed ID: 35340062
[TBL] [Abstract][Full Text] [Related]
2. Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study.
Saag KG; Wagman RB; Geusens P; Adachi JD; Messina OD; Emkey R; Chapurlat R; Wang A; Pannacciulli N; Lems WF
Lancet Diabetes Endocrinol; 2018 Jun; 6(6):445-454. PubMed ID: 29631782
[TBL] [Abstract][Full Text] [Related]
3. Teriparatide Followed by Denosumab in Premenopausal Idiopathic Osteoporosis: Bone Microstructure and Strength by HR-pQCT.
Agarwal S; Shiau S; Kamanda-Kosseh M; Bucovsky M; Kil N; Lappe JM; Stubby J; Recker RR; Guo XE; Shane E; Cohen A
J Bone Miner Res; 2023 Jan; 38(1):35-47. PubMed ID: 36335582
[TBL] [Abstract][Full Text] [Related]
4. Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT Study.
Ramchand SK; David NL; Lee H; Bruce M; Bouxsein ML; Leder BZ; Tsai JN
J Bone Miner Res; 2021 Jan; 36(1):41-51. PubMed ID: 32790196
[TBL] [Abstract][Full Text] [Related]
5. Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial.
Saag KG; Pannacciulli N; Geusens P; Adachi JD; Messina OD; Morales-Torres J; Emkey R; Butler PW; Yin X; Lems WF
Arthritis Rheumatol; 2019 Jul; 71(7):1174-1184. PubMed ID: 30816640
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension.
Ramchand SK; David NL; Lee H; Bruce M; Bouxsein ML; Tsai JN; Leder BZ
J Bone Miner Res; 2023 Jan; 38(1):26-34. PubMed ID: 36333954
[TBL] [Abstract][Full Text] [Related]
7. Effect of Denosumab on Peripheral Compartmental Bone Density, Microarchitecture and Estimated Bone Strength in De Novo Kidney Transplant Recipients.
Bonani M; Meyer U; Frey D; Graf N; Bischoff-Ferrari HA; Wüthrich RP
Kidney Blood Press Res; 2016; 41(5):614-622. PubMed ID: 27622692
[TBL] [Abstract][Full Text] [Related]
8. Effects of Denosumab and Teriparatide Transitions on Bone Microarchitecture and Estimated Strength: the DATA-Switch HR-pQCT study.
Tsai JN; Nishiyama KK; Lin D; Yuan A; Lee H; Bouxsein ML; Leder BZ
J Bone Miner Res; 2017 Oct; 32(10):2001-2009. PubMed ID: 28608571
[TBL] [Abstract][Full Text] [Related]
9. Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study).
Tsai JN; Uihlein AV; Burnett-Bowie SM; Neer RM; Derrico NP; Lee H; Bouxsein ML; Leder BZ
J Clin Endocrinol Metab; 2016 May; 101(5):2023-30. PubMed ID: 26964731
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study.
Tsai JN; Uihlein AV; Burnett-Bowie SA; Neer RM; Zhu Y; Derrico N; Lee H; Bouxsein ML; Leder BZ
J Bone Miner Res; 2015 Jan; 30(1):39-45. PubMed ID: 25043459
[TBL] [Abstract][Full Text] [Related]
11. Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT.
Tang XL; Qin L; Kwok AW; Zhu TY; Kun EW; Hung VW; Griffith JF; Leung PC; Li EK; Tam LS
Osteoporos Int; 2013 Jun; 24(6):1817-26. PubMed ID: 23104200
[TBL] [Abstract][Full Text] [Related]
12. Age-related reference data of bone microarchitecture, volumetric bone density, and bone strength parameters in a population of healthy Brazilian men: an HR-pQCT study.
Alvarenga JC; Caparbo VF; Domiciano DS; Pereira RMR
Osteoporos Int; 2022 Jun; 33(6):1309-1321. PubMed ID: 35059775
[TBL] [Abstract][Full Text] [Related]
13. The effect of denosumab and alendronate on trabecular plate and rod microstructure at the distal tibia and radius: A post-hoc HR-pQCT study.
Hu YJ; Chines A; Shi Y; Seeman E; Guo XE
Bone; 2022 Jan; 154():116187. PubMed ID: 34530172
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy-Related Bone Mineral and Microarchitecture Changes in Women Aged 30 to 45 Years.
Ó Breasail M; Prentice A; Ward K
J Bone Miner Res; 2020 Jul; 35(7):1253-1262. PubMed ID: 32119748
[TBL] [Abstract][Full Text] [Related]
15. Bone microarchitecture in patients with autoimmune hepatitis.
Schmidt C; Stürznickel J; Strahl A; Oheim R; Weiler-Normann C; Sebode M; Barvencik F; Lohse AW; Schinke T; Amling M; Schramm C; Rolvien T
J Bone Miner Res; 2021 Jul; 36(7):1316-1325. PubMed ID: 33724539
[TBL] [Abstract][Full Text] [Related]
16. Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy.
Cohen A; Dempster DW; Müller R; Guo XE; Nickolas TL; Liu XS; Zhang XH; Wirth AJ; van Lenthe GH; Kohler T; McMahon DJ; Zhou H; Rubin MR; Bilezikian JP; Lappe JM; Recker RR; Shane E
Osteoporos Int; 2010 Feb; 21(2):263-73. PubMed ID: 19455271
[TBL] [Abstract][Full Text] [Related]
17. Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strength.
Cheung AM; Majumdar S; Brixen K; Chapurlat R; Fuerst T; Engelke K; Dardzinski B; Cabal A; Verbruggen N; Ather S; Rosenberg E; de Papp AE
J Bone Miner Res; 2014 Aug; 29(8):1786-94. PubMed ID: 24643905
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover.
Burghardt AJ; Kazakia GJ; Sode M; de Papp AE; Link TM; Majumdar S
J Bone Miner Res; 2010 Dec; 25(12):2558-71. PubMed ID: 20564242
[TBL] [Abstract][Full Text] [Related]
19. Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures.
Stein EM; Liu XS; Nickolas TL; Cohen A; Thomas V; McMahon DJ; Zhang C; Yin PT; Cosman F; Nieves J; Guo XE; Shane E
J Bone Miner Res; 2010 Dec; 25(12):2572-81. PubMed ID: 20564238
[TBL] [Abstract][Full Text] [Related]
20. Reliability of Annual Changes and Monitoring Time Intervals for Bone Strength, Size, Density, and Microarchitectural Development at the Distal Radius and Tibia in Children: A 1-Year HR-pQCT Follow-Up.
Bunyamin A; Björkman K; Kawalilak C; Hosseinitabatabaei S; Teare A; Johnston J; Kontulainen S
J Bone Miner Res; 2019 Jul; 34(7):1297-1305. PubMed ID: 30730590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
